All In Biotech

Drug Trial Radar · NCT07477691

Immune Modulation During Palynziq® Treatment in Adults (IMPALA)

A Phase 4 Study of Immune Modulation During Palynziq® Treatment in Adults With Phenylketonuria (PKU)

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

May 29, 2026

Primary completion

Sep 30, 2027

Study completion Sep 30, 2027

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Mar 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study 165-401 is a Phase 4, open-label study designed to examine the concomitant use of methotrexate (MTX) to suppress immune responses to Palynziq and improve tolerability and efficacy in adults with PKU.

Conditions

  • Phenylketonuria

Interventions

  • PegvaliaseBiological

    Pegvaliase (Palynziq) administered by subcutaneous injection. Dosing follows U.S. Prescribing Information and investigator judgement.

  • MethotrexateDrug

    Oral methotrexate 15 mg administered once weekly during the Tolerability Period and the Combination Treatment Period.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in blood Phe levels from baseline to Week 25 and Week 49Time frame: Baseline to Week 25 and Baseline to Week 49
  2. Anti-PEG IgG, IgM, anti-PAL IgG, IgM levels at Weeks 5, 9, 25, and 49Time frame: Baseline to Week 5, Week 9, Week 25, and Week 49

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • UCLA Dept. of Human Genetics

    Los Angeles, California · Recruiting

  • Children's Hospital Colorado

    Aurora, Colorado · Recruiting

  • University Of South Florida Medical Center

    Tampa, Florida · Recruiting

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois · Recruiting

  • Indiana University School of Medicine

    Indianapolis, Indiana · Recruiting

  • University of Minnesota Medical School

    Minneapolis, Minnesota · Recruiting

  • University of Rochester Medical Center (URMC)

    Rochester, New York · Recruiting

  • Oregon Health & Science University (OHSU) - PARENT

    Portland, Oregon · Recruiting

  • University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania · Not yet recruiting

  • UT Southwestern Medical Center

    Dallas, Texas · Recruiting

  • University of Utah Hospital

    Salt Lake City, Utah · Not yet recruiting

  • Children's Hospital of Wisconsin

    Milwaukee, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.